Department of Health and Human Services November 21, 2006 – Federal Register Recent Federal Regulation Documents

Proposed Data Collections Submitted for Public Comment and Recommendations
Document Number: E6-19634
Type: Notice
Date: 2006-11-21
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Oral Dosage Form New Animal Drugs; Ivermectin Paste
Document Number: E6-19616
Type: Rule
Date: 2006-11-21
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental abbreviated new animal drug application (ANADA) filed by Virbac AH, Inc. The supplemental ANADA provides revised labeling for oral use of generic ivermectin paste in horses that conforms to the pioneer product label.
New Animal Drugs For Use in Animal Feeds; Ractopamine
Document Number: E6-19615
Type: Rule
Date: 2006-11-21
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of two supplemental new animal drug applications (NADAs) filed by Elanco Animal Health. The first supplemental NADA revises the concentrations of ractopamine hydrochloride in single-ingredient Type B and C medicated swine feeds used for increased rate of weight gain, improved feed efficiency, and increased carcass leanness. The other supplemental NADA revises the concentrations of ractopamine hydrochloride used with tylosin phosphate in two-way Type C medicated swine feeds to conform with approved single-ingredient ractopamine use.
New Animal Drugs for Use in Animal Feeds; Lasalocid
Document Number: E6-19614
Type: Rule
Date: 2006-11-21
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Alpharma Inc. The supplemental NADA provides for the use of lasalocid Type A medicated articles containing 20 percent lasalocid activity per pound to make free-choice Type C medicated feeds used for increased rate of weight gain in pasture cattle (slaughter, stocker, feeder cattle, and dairy and beef replacement heifers).
National Institute on Alcohol Abuse and Alcoholism; Notice of Meeting
Document Number: 06-9322
Type: Notice
Date: 2006-11-21
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Child Health and Human Development; Notice of Closed Meetings
Document Number: 06-9321
Type: Notice
Date: 2006-11-21
Agency: Department of Health and Human Services, National Institutes of Health
National Center for Research Resources; Notice of Closed Meeting
Document Number: 06-9320
Type: Notice
Date: 2006-11-21
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings
Document Number: 06-9319
Type: Notice
Date: 2006-11-21
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Amended Notice of Meeting
Document Number: 06-9318
Type: Notice
Date: 2006-11-21
Agency: Department of Health and Human Services, National Institutes of Health
National Eye Institute; Notice of Closed Meeting
Document Number: 06-9317
Type: Notice
Date: 2006-11-21
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Environmental Health Sciences; Notice of Closed Meeting
Document Number: 06-9316
Type: Notice
Date: 2006-11-21
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Document Number: 06-9315
Type: Notice
Date: 2006-11-21
Agency: Department of Health and Human Services, National Institutes of Health
National Human Genome Research Institute; Notice of Closed Meetings
Document Number: 06-9314
Type: Notice
Date: 2006-11-21
Agency: Department of Health and Human Services, National Institutes of Health
Electronic Submission of Regulatory Information, and Creating an Electronic Platform for Enhanced Information Management; Public Hearing
Document Number: 06-9313
Type: Notice
Date: 2006-11-21
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing a public hearing to solicit general views and information from interested persons on issues concerning the electronic submission of product information to the agency. In particular, FDA is seeking these views and information from interested persons on the feasibility and effect of an all-electronic submission environment, as well as issues related to an electronic regulatory information exchange platform. To help solicit such information and views, FDA is seeking responses to specific questions (see section IV of this document).
National Eye Institute; Notice of Closed Meeting
Document Number: 06-9300
Type: Notice
Date: 2006-11-21
Agency: Department of Health and Human Services, National Institutes of Health
Administration for Children and Families
Document Number: 06-9281
Type: Notice
Date: 2006-11-21
Agency: Department of Health and Human Services, Children and Families Administration
Pursuant to section 814 of the Native American Programs Act of 1974 (the Act) 42 U.S.C. 2992b-1, ANA herein describes its proposed interpretive rules, statements of general policy and rules of agency procedure or practice in relation to the Social and Economic Development Strategies (hereinafter referred to as SEDS), Native Language Preservation and Maintenance (hereinafter referred to as Native Language), Environmental Regulatory Enhancement (hereinafter referred to as Environmental), Environmental Mitigation (hereinafter referred to as Mitigation), Improving the Well-Being of Children Native American Healthy Marriage Initiative (hereinafter referred to as Healthy Marriage) programs and any Special Initiatives. Under the statute, ANA is required to provide members of the public an opportunity to comment on proposed changes in interpretive rules, statements of general policy and rules of agency procedure or practice and to give notice of the final adoption of such changes at least thirty (30) days before the changes become effective. This Notice also provides additional information about ANA's plan for administering the programs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.